Archive for September, 2018

Recent Rosacea Blog Posts

Galderma for sale – why we need the right buyer

A for-sale sign is hanging outside the Galderma shop, shall we make them an offer? The rosacea behemoth that is Galderma could be about to change hands, read on to find out this sale could mean for rosacea sufferers and why we all have an interest in the new owner. Galderma was created in 1981 […]

Continue Reading

BioPharmX developing topical Minocycline Gel 1%

A phase 2 trial for a topical minocycline gel for the papules and pustules of rosacea has just been listed. BiopharmX, the sponsors of the trial, suggest that the product BPX-04 has “good tolerability and promising efficacy in rosacea” and also showcases “the value of our anhydrous hydrophilic topical delivery system.” The trial will compare the […]

Continue Reading

Generic Oracea – sadly just not going to happen

A recent ruling from a Delaware Federal judge has confirmed that Galderma’s patent protection covering Oracea is secure, and confirming that generic Oracea is just not going to happen. This most recent ruling found that Amneal Pharmaceuticals’s attempt to create a generic version of the once-daily low dose doxycycline treatment infringes 5 of Galderma’s US […]

Continue Reading



Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.